SEIDENBERG BETH C
Transactions
50
Companies
11
Filings
11
CIK
0001184592
Recent Transactions
- Purchase
- Award
- Award
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
- Sale
- Sale
- Sale
- Sale
- Sale
- Award
- Award
- Award
- Award
- Award
- Conversion
- Conversion
Series A-2 Redeemable Convertible Preferred Stock
2024-02-12−8,830,901→ 0 total - Conversion
Series B Redeemable Convertible Preferred Stock
2024-02-12−4,006,624→ 0 total - Conversion
Series B Redeemable Convertible Preferred Stock
2024-02-12−3,349,538→ 0 total - Conversion
- Conversion
Series A-1 Redeemable Convertible Preferred Stock
2024-02-12−4,401,771→ 0 total - Award
- Disposition to Issuer
- Conversion
- Conversion
- Conversion
- Award
- Disposition to Issuer
- Conversion
- Conversion
- Conversion
- Purchase
- Conversion
- Conversion
- Conversion
- Conversion
- Other
- Other
- Other
- Other
- Other
- Other
- Award
Non-Qualified Stock Option (Right to Buy)
2023-05-31+79,500→ 79,500 total - Award
- Award
Companies
11ACELYRIN, Inc.
Director
- $AMGN
AMGEN INC
Sr VP, Dev & Chief Medical Ofc
ARMO BioSciences, Inc.
Director, 10% Owner
- $ATRA
Atara Biotherapeutics, Inc.
Director, 10% Owner
- $BCRX
BIOCRYST PHARMACEUTICALS INC
Director
Epizyme, Inc.
Director, 10% Owner
- $KYTX
Kyverna Therapeutics, Inc.
Director, 10% Owner
- $PGNY
Progyny, Inc.
Director
- $SGMT
Sagimet Biosciences Inc.
Director
TESARO, Inc.
Director
- $VERA
Vera Therapeutics, Inc.
Director
Recent Filings
11- 4
SEIDENBERG BETH C
Dec 22, 2025
- 4
SEIDENBERG BETH C
Jun 10, 2025
- 4
SEIDENBERG BETH C
Jun 2, 2025
- 4
SEIDENBERG BETH C
May 23, 2025
- 4
SEIDENBERG BETH C
May 16, 2025
- 4
SEIDENBERG BETH C
Oct 30, 2024
- 4
SEIDENBERG BETH C
Sep 20, 2024
- 4
SEIDENBERG BETH C
Jun 11, 2024
- 4
SEIDENBERG BETH C
Jun 7, 2024
- 4
SEIDENBERG BETH C
May 28, 2024
- 4
SEIDENBERG BETH C
May 17, 2024
Address
2190 PARKWAY LAKE DRIVE
BIRMINGHAM, AL, 35244-